Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
---|
07/27/2000 | CA2323710A1 Compositions for oxidation dyeing keratin fibres comprising a cationic coupler, novel cationic couplers, their use for oxidation dyeing and dyeing methods |
07/27/2000 | CA2323709A1 Naphthalene cationic coupler for oxidation dyeing of keratin fiber |
07/27/2000 | CA2323708A1 Novel cationic couplers and their use for oxidation dyeing |
07/27/2000 | CA2323698A1 Novel cationic 2-sulphonylaminophenols, their use as couplers for oxidation dyeing, compositions containing them and dyeing methods |
07/27/2000 | CA2323003A1 Novel cationic 2-acylaminophenols, their use as coupler for oxidation dyeing, compositions containing them, and dyeing methods |
07/26/2000 | EP1022271A1 Cationic monobenzenic dyes, their use for the oxydative dyeing of keratinic fibres ,dye compositions and dyeing processes |
07/26/2000 | EP1021473A1 Bis(alkylamino)alkylether compounds and the use thereof |
07/26/2000 | EP1021425A1 N-aminoalkyl-2-anthraquinonecarboxamides; dopamine receptor subtype specific ligands |
07/26/2000 | EP1021398A1 Pesticidal compositions |
07/26/2000 | EP1021199A1 PEPTIDE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
07/26/2000 | EP1021184A1 Use of flunarizine for the topical treatment of glaucoma |
07/26/2000 | CN1261358A Angiogenesis inhiting 5-substituted-1,2,4-thiadiazolyl derivatives |
07/26/2000 | CN1261347A Remedies/preventives for frequent urination/urinary incontinence and tropone derivatives |
07/26/2000 | CN1054850C Piperazine compounds used in therapy |
07/26/2000 | CN1054849C Process for producing quaternary glycine nitriles |
07/26/2000 | CN1054848C New benzopyran derivatives, their process of preparation and pharmaceutical compositions |
07/25/2000 | US6093742 Inhibitors of p38 |
07/25/2000 | US6093735 Selective β-3 adrenergic agonists |
07/25/2000 | US6093733 Muscarinic receptor agonists |
07/25/2000 | CA2205285C Benzoic acid derivative and pharmaceutical composition |
07/25/2000 | CA2167688C Methods and compositions for inhibiting uridine secretion |
07/20/2000 | WO2000042012A1 φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS |
07/20/2000 | WO2000042011A1 Amide compounds |
07/20/2000 | WO2000042010A1 Contrast media for angiography |
07/20/2000 | WO2000042004A1 Benzenic sulphonamide derivatives and their uses |
07/20/2000 | WO2000042001A1 ((aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy |
07/20/2000 | WO2000041996A1 Production of acrylic monomers |
07/20/2000 | WO2000041698A1 φ-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS |
07/20/2000 | DE19901198A1 Verfahren zur Herstellung von 2,2'-Dimorpholinodiethylether A process for the preparation of 2,2'-dimorpholinodiethyl |
07/20/2000 | CA2360560A1 Contrast media for angiography |
07/20/2000 | CA2359244A1 .omega.-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors |
07/20/2000 | CA2356359A1 Production of acrylic monomers |
07/20/2000 | CA2356290A1 Benzenic sulphonamide derivatives and their uses |
07/19/2000 | EP1020455A1 Process for the preparation of 2,2'-dimorpholinodiethylether |
07/19/2000 | EP1020448A2 Arylheterocycles with herbicidal activity |
07/19/2000 | EP1020443A1 Process for producing piperazinesulfonamide derivatives and salts thereof |
07/19/2000 | EP1020434A1 3-amidinoaniline derivatives, activated blood coagulation factor x inhibitors, and intermediates for producing both |
07/19/2000 | EP1020426A1 Amine derivatives and process for producing the same |
07/19/2000 | EP1019368A1 Acylsulfamoyl benzoic acid amides, plant protection agents containing said acylsulfamoyl benzoic acid amides, and method for producing the same |
07/19/2000 | EP1019367A1 Derivatives of 2,5- and 3,5-disubstituted anilines, their preparation and use |
07/19/2000 | EP1019364A2 Inhibitors of protein tyrosine phosphatase |
07/19/2000 | EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
07/19/2000 | EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
07/19/2000 | EP1018879A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses |
07/19/2000 | EP1018876A1 Use of hydroxylamine derivatives, and method and preparations for increasing the tolerance of field crops against weather stresses |
07/19/2000 | CN1054604C Processf or preparing morpholine hydrochloride as precursor of monoxydine hydrocloride |
07/19/2000 | CN1054598C Pharmacalogically active hydrazine derivatives and process for preparation thereof |
07/19/2000 | CA2296059A1 Novel cationic mono-benzenic dyes, their use for oxydation dyeing of keratinic fibres, dyeing compositions and dyeing methods |
07/18/2000 | US6090958 N-(8-carboxyoctyl)-o-hydroxybenzamide and salts |
07/18/2000 | US6090808 Dimeric piperidine, tetrahydropyridine and piperazine derivatives |
07/13/2000 | WO2000040572A1 1-phenyl-4-(1-[2-aryl]cyclopropyl) methylpiperazines: dopamine receptor ligands |
07/13/2000 | WO2000040571A1 Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor xa activity) |
07/13/2000 | WO2000040558A1 Aspartic protease inhibitors |
07/13/2000 | WO2000040550A1 Method for preparing nitroxides |
07/13/2000 | WO2000040529A1 Colchinol derivatives as vascular damaging agents |
07/13/2000 | WO2000040237A1 Antiviral method using mek inhibitors |
07/13/2000 | CA2359989A1 1-phenyl-4-(1-¬2-aryl|cyclopropyl) methylpiperazines: dopamine receptor ligands |
07/13/2000 | CA2358578A1 Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor xa activity) |
07/13/2000 | CA2358438A1 Antiviral method using mek inhibitors |
07/13/2000 | CA2355302A1 Colchinol derivatives as vascular damaging agents |
07/12/2000 | EP1018008A2 Method of identification of leads or active compounds |
07/12/2000 | EP1017378A1 Amide derivatives for the treatment of diseases mediated by cytokines |
07/12/2000 | EP0822932B1 Piperidine derivatives as diuretic |
07/12/2000 | EP0812320B1 Amorphous piretanide, piretanide polymorphs, process for their preparation and their use |
07/12/2000 | EP0792289B1 Low molecular weight peptidomimetic growth hormone secretagogues |
07/12/2000 | CN1259577A Micro-organism biotransformation method |
07/12/2000 | CN1054372C Amino substituted benzosulfonylurea and -thiorea prepn. and pharmaceutical use of same |
07/11/2000 | US6087412 Ophthalmic molding blend of macromolecule containing photoinitiator, hydrophilic vinyl monomer and crosslinker |
07/11/2000 | US6087367 Potent inducers of terminal differentiation and methods of use thereof |
07/11/2000 | US6087365 Treating drug-resistant malaria in a mammal |
07/11/2000 | US6087359 A matrix metalloprotease enzyme inhibitor |
07/11/2000 | US6087346 Sigma receptor ligands and the use thereof |
07/11/2000 | US6087304 Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
07/06/2000 | WO2000039111A1 Antithrombotic amides |
07/06/2000 | WO2000039110A1 Homopiperazine derivatives as selective emopamil inhibitors |
07/06/2000 | WO2000039092A1 HETEROCYCLIC AMIDES AS INHIBITORS OF FACTOR Xa |
07/06/2000 | WO2000039088A1 Glucagon antagonists/inverse agonists |
07/06/2000 | WO2000039081A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
07/06/2000 | WO2000039077A2 Thyroid receptor ligands |
07/06/2000 | WO2000039070A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
07/06/2000 | WO2000039062A1 Liquid crystalline trifluoro-substituted compounds |
07/06/2000 | WO2000039055A1 Rapid purification by polyaromatic quench reagents |
07/06/2000 | WO2000038813A1 Dehydration process |
07/06/2000 | WO2000038685A1 Solution phase synthesis of compounds including amine alcohol functionality |
07/06/2000 | WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS |
07/06/2000 | CA2358315A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
07/06/2000 | CA2358091A1 Antithrombotic amides |
07/06/2000 | CA2356319A1 Thyroid receptor ligands |
07/06/2000 | CA2356214A1 Heterocyclic amides as inhibitors of factor xa |
07/06/2000 | CA2353480A1 Dehydration process |
07/05/2000 | EP1015421A1 New phenylamidine derivatives, a process for preparing the same and their use as medicaments |
07/05/2000 | EP1015008A1 Compounds and compositions for delivering active agents |
07/05/2000 | EP1014966A1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
07/05/2000 | EP1014962A1 Antithrombotic agents |
07/05/2000 | CN1259120A Calcilytic compounds |
07/05/2000 | CN1259119A Substituted 3,3-diamino-2-propenenitriles their preparation and use |
07/05/2000 | CN1259118A Organic compound |
07/04/2000 | US6084098 Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands |
07/04/2000 | US6084096 Triethylenediamine and piperazine synthesis using zeolite catalysts modified with a silicon-containing compound |
07/04/2000 | US6083960 Constrained somatostatin agonists and antagonists |